These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 17888220)
1. Interleukin-1 receptor antagonist is associated with both lipid metabolism and inflammation in rheumatoid arthritis. Ljung L; Olsson T; Engstrand S; Wållberg-Jonsson S; Söderberg S; Rantapää-Dahlqvist S Clin Exp Rheumatol; 2007; 25(4):617-20. PubMed ID: 17888220 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate. Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. Tsai SY; Chung KH; Wu JY; Kuo CJ; Lee HC; Huang SH J Affect Disord; 2012 Jan; 136(1-2):110-116. PubMed ID: 21962564 [TBL] [Abstract][Full Text] [Related]
4. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission. Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211 [TBL] [Abstract][Full Text] [Related]
5. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate. Seitz M; Zwicker M; Villiger PM J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386 [TBL] [Abstract][Full Text] [Related]
6. Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. Forsblad d'Elia H; Pullerits R; Carlsten H; Bokarewa M Rheumatology (Oxford); 2008 Jul; 47(7):1082-7. PubMed ID: 18511473 [TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Hope S; Ueland T; Steen NE; Dieset I; Lorentzen S; Berg AO; Agartz I; Aukrust P; Andreassen OA Schizophr Res; 2013 Apr; 145(1-3):36-42. PubMed ID: 23403415 [TBL] [Abstract][Full Text] [Related]
8. [Serum leptin levels in patients with rheumatoid arthritis are correlated with body mass index]. Nishiya K; Nishiyama M; Chang A; Shinto A; Hashimoto K Rinsho Byori; 2002 May; 50(5):524-7. PubMed ID: 12078053 [TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis. Almeida-Santiago C; Quevedo-Abeledo JC; Hernández-Hernández V; de Vera-González A; Gonzalez-Delgado A; González-Gay MÁ; Ferraz-Amaro I Sci Rep; 2022 Aug; 12(1):13698. PubMed ID: 35953706 [TBL] [Abstract][Full Text] [Related]
10. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325 [TBL] [Abstract][Full Text] [Related]
11. Behavioral recovery from acute hypoxia is reliant on leptin. Sherry CL; Kramer JM; York JM; Freund GG Brain Behav Immun; 2009 Feb; 23(2):169-75. PubMed ID: 18854211 [TBL] [Abstract][Full Text] [Related]
12. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626 [TBL] [Abstract][Full Text] [Related]
13. Elevated plasma fractalkine levels are associated with higher levels of IL-6, Apo-B, LDL-C and insulin, but not with body composition in a large female twin sample. Franco L; Williams FM; Trofimov S; Surdulescu G; Spector T; Livshits G Metabolism; 2013 Aug; 62(8):1081-7. PubMed ID: 23477808 [TBL] [Abstract][Full Text] [Related]
14. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia. Schmid I; Schmitt M; Streiter M; Meilbeck R; Haas RJ; Stachel DK Eur J Med Res; 2005 Nov; 10(11):457-61. PubMed ID: 16354598 [TBL] [Abstract][Full Text] [Related]
15. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? Meier CA; Bobbioni E; Gabay C; Assimacopoulos-Jeannet F; Golay A; Dayer JM J Clin Endocrinol Metab; 2002 Mar; 87(3):1184-8. PubMed ID: 11889184 [TBL] [Abstract][Full Text] [Related]
16. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly. Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791 [TBL] [Abstract][Full Text] [Related]
17. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343 [TBL] [Abstract][Full Text] [Related]
18. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia. Lin Y; Peng Y; He S; Xu J; Shi Y; Su Y; Zhu C; Zhang X; Zhou R; Cui D Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):71-78. PubMed ID: 29410009 [TBL] [Abstract][Full Text] [Related]
19. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
20. Effects of DMARDs on IL-1Ra levels in rheumatoid arthritis: is there any evidence? Cutolo M Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S26-31. PubMed ID: 14989426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]